Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease

Abstract

Our findings suggest that in IBD psychological variables, particularly depressive coping, are more predictive than medical variables for disease-related concerns and other variables of health-related quality of life. Further studies are needed to examine the effects that the way of coping with disease have on long-term outcome in IBD.

The objective and subjective dimension of quality of life in patients with inflammatory bowel diseases treated on surgical wards

“…Russel i wsp. wykazali również zależność pomiędzy oceną jakości życia a stanem emocjonalnym i dolegliwościami jelitowymi [12]. W badaniach Palia stwierdzono złe oceny jakości życia w porównaniu z ocenami w badaniach holenderskich i angielskich.…”

Stress Coping, Distress, and Health Perceptions in Inflammatory Bowel Disease and Community Controls

“…Those studies relying on IBD clinic samples have found IBD patients are more likely to use maladaptive stress coping strategies than those without IBD 12 . These approaches, which can include withdrawal and catastrophic thinking, have been associated with greater distress in IBD patients, adverse health outcomes, and poorer outcome after surgery [30][31][32] . In a community-based IBD sample, recruited through online IBD groups and GI specialist offices, avoidant coping was associated with poorer outcomes, however a comparison group was not included 33 .…”

221 Psychiatric Co-Morbidity Is Associated With Increased Risk of Surgery in Crohns Disease

“…Prior studies have mostly examined the effect of such psychiatric co-morbidity on symptombased activity indices and health-related quality of life 15,16 , both of which may be confounded by the co-existence of functional symptoms [32][33][34] . Using disease-specific hard endpoints, we demonstrate that co-existing psychiatric co-morbidity was independently associated with a modestly increased risk of surgery in CD with a stronger effect for anxiety.…”

“…Psychiatric co-morbidity has been mostly examined in the context of its effect on healthrelated quality of life in CD and UC 15,16 . However, the few studies that have previously examined the effect of psychiatric co-morbidity on disease activity, in particular, on the subsequent course of CD and UC, have several limitations including reliance on symptombased disease activity indices that often correlate poorly with objective disease activity and short duration of follow-up 2,6,7,[17][18][19][20] .…”